Home › NDC Lookup › RxCUI directory › RxCUI 1598268

Weight Management 3 ML liraglutide 6 MG/ML Pen Injector [Saxenda] — RxCUI 1598268

Name: Weight Management 3 ML liraglutide 6 MG/ML Pen Injector [Saxenda] (RxCUI 1598268)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1598268 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1598268

Official nameWeight Management 3 ML liraglutide 6 MG/ML Pen Injector [Saxenda]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asWeight Management Saxenda 6 MG/ML Pen Injector; Saxenda 6 MG/ML in 3 mL Weight Management Pen Injector; 3 ML Saxenda 6 MG/ML Weight Management Pen Injector; Saxenda 18 MG per 3 ML Weight Management Pen Injector

FDA products mapped2

Package NDCs mapped4

Reported Medicaid activity (SDUD)28,648 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Liraglutide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Saxenda is a daily injectable medication that works by mimicking a hormone called GLP-1, which your body naturally makes after eating. It helps reduce your appetite, makes you feel...
What exactly is Saxenda and how is it different from other weight-loss options?
Yes, nausea is the most common side effect, and it's especially common in the first few weeks. That's actually why your prescriber starts you at a low dose and slowly increases it...
The nausea is really bothering me — is that normal, and will it get better?

📖 Read our full Liraglutide Injection guide →

🕸️ Concept Web — How Weight Management 3 ML liraglutide 6 MG/ML Pen I... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Weight Management 3 ML liraglutide 6 MG/ML Pen Injector [Saxenda] RxCUI 1598268 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Liraglutide 475968 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Saxenda 1598264 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Liraglutide Pen Injector 1653594 SCDF
- Liraglutide Injectable Product 1163230 SCDG
- Liraglutide Pen Injector [Saxenda] 1653600 SBDF
- Saxenda Injectable Product 1598267 SBDG
- Pen Injector 1649571 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Weight Management 3 ML liraglutide 6 MG/ML Pen Injector 2735350 SCD
- Liraglutide 6 MG/ML 897120 SCDC
- Liraglutide 6 MG/ML [Saxenda] 1598265 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Weight Management 3 ML liraglutide 6 MG/ML Pen Injector SCD · 2735350
Liraglutide 6 MG/ML SCDC · 897120
Liraglutide Pen Injector SCDF · 1653594
Liraglutide Injectable Product SCDG · 1163230

Brand-Name Concepts

Liraglutide 6 MG/ML [Saxenda] SBDC · 1598265
Liraglutide Pen Injector [Saxenda] SBDF · 1653600
Saxenda Injectable Product SBDG · 1598267
Saxenda BN · 1598264

📦 FDA Products & Package NDCs

2 products · 4 package NDCs

4 package NDCs map to RxCUI 1598268 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00169-2800-15	5 SYRINGE, PLASTIC in 1 CARTON (0169-2800-15) / 3 mL in 1 S...	Saxenda	Novo Nordisk Pharmaceutical Industries, LP	2015-01-19
00169-2800-90	1 SYRINGE, PLASTIC in 1 CARTON (0169-2800-90) / 3 mL in 1 S...	Saxenda	Novo Nordisk Pharmaceutical Industries, LP	2015-01-19
00169-2800-97	1 SYRINGE, PLASTIC in 1 CARTON (0169-2800-97) / 3 mL in 1 S...	Saxenda	Novo Nordisk Pharmaceutical Industries, LP	2015-01-19
50090-4257-00	5 SYRINGE, PLASTIC in 1 CARTON (50090-4257-0) / 3 mL in 1 S...	Saxenda	A-S Medication Solutions	2019-04-09

Observed labelers: Novo Nordisk Pharmaceutical Industries, LP (3) · A-S Medication Solutions (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ml · median

$87.1660

Range $87.1660–$87.1660 · middle 50% $87.1660–$87.1660 · 1 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.